Advanced SearchSearch Tips
Effects of Xylazine or Acepromazine in dogs under constant rate infusion with alfaxalone
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Effects of Xylazine or Acepromazine in dogs under constant rate infusion with alfaxalone
Yun, Sungho; Kwon, Young-Sam;
  PDF(new window)
The anesthetic depth and cardiovascular effect of alfaxalone constant rate infusion in dogs premedicated with xylazine or acepromazine were evaluated. Ten dogs were randomly allocated into 2 groups. In group AA, dogs were premedicated with 0.02 mg/kg of intravenous acepromazine at 15 min before induction. In group XA 1.1 mg/kg of intravenous xylazine was premedicated at 5 min before induction. The anesthesia was maintained with 6 mg/kg/hr of alfaxalone after induction with 2 mg/kg alfaxalone in both groups. In both of groups, the qualities of induction were satisfactory without any adverse event, but adequate analgesia could not be provided, according to the withdrawal test. and implied a slight hypoxemia state in XA group, while those values of group AA were not significantly changed. The acepromazine and alfaxalone combination induce mild tachycardia. The bispectral index score were significantly decreased in group XA, compared with that in group AA. The premedication of xylazine before alfaxalone constant rate infusion in this study could provide adequate analgesia during 30 min, while the premedication with acepromazine could not.
Acepromazine;Alfaxalone;Xylazine;Bispectral index score;
 Cited by
Baldessarini RJ, Tarazi FI. 2005. Pharmacotherapy of psychosis and mania. pp. 461-500. In: Brunton LL, Lazo JS, Parker KL (ed.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th ed. McGrawHill, New York.

Barnhart MD, Hubbell JAE, Muir WW. 2000. Evaluation of the analgesic properties of acepromazine maleate, oxymorphone, medetomidine and a combination of acepromazine-oxymorphone. Vet Anaesth Analg 27: 89-96. crossref(new window)

Bergadano A, Andersen OK, Arendt-Nielsen L, Spadavecchia C. 2009. Modulation of nociceptive withdrawal reflexes evoked by single and repeated nociceptive stimuli in conscious dogs by low-dose acepromazine. Vet Anaesth Analg 36: 261-272. crossref(new window)

Bleijenberg EH, van Oostrom H, Akkerdaas LC, Doornenbal A, Hellebrekers LJ. 2011. Bispectral index and the clinically evaluated anaesthetic depth in dogs. Vet Anaesth Analg 38: 536-543. crossref(new window)

Boyd CJ, McDonell WN, Valliant A. 1991. Comparative hemodynamic effects of halothane and halothane-acepromazine at equipotent doses in dogs. Can J Vet Res 55: 107-112.

Cullen LK. 1999. Xylazine and medetomidine in small animals: these drugs should be used carefully. Aust Vet J 77: 722-723. crossref(new window)

Dyson DH, Maxie MG, Schnurr D. 1998. Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario. J Am Anim Hosp Assoc 34: 325-335. crossref(new window)

Ferre PJ, Pasloske K, Whittem T, Ranasinghe MG, Li Q, Lefebvre HP. 2006. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. Vet Anaesth Analg 33: 229-236. crossref(new window)

Greene SA. 1999. Pros and cons of using alpha-2 agonists in small animal anesthesia practice. Clin Tech Small Anim Pract 14: 10-14. crossref(new window)

Hall LW, Clarke KW, Trim CM. 2001. Veterinary anaesthesia. pp. 561. 10th ed. Saunders.New York.

Hall TL, Duke T, Townsend HG, Caulkett NA, Cantwell SL. 1999. The effect of opioid and acepromazine premedication on the anesthetic induction dose of propofol in cats. Can Vet J 40: 867-870.

Herbert GL, Bowlt KL, Ford-Fennah V, Covey-Crump GL, Murrell JC. 2012. Alfaxalone for total intravenous anaesthesia in dogs undergoing ovariohysterectomy: a comparison of premedication with acepromazine or dexmedetomidine. Vet Anaesth Analg 40: 124-133.

Ilback NG, Stalhandske T. 2003. Cardiovascular effects of xylazine recorded with telemetry in the dog. J Vet Med A Physiol Pathol Clin Med 50: 479-483. crossref(new window)

Lemke KA. 2004. Perioperative use of selective alpha-2 agonists and antagonists in small animals. Can Vet J 45: 475-480.

Lukasik VM, Gillies RJ. 2003. Animal anaesthesia for in vivo magnetic resonance. NMR Biomed 16: 459-467. crossref(new window)

Montgomery GH, DuHamel KN, Redd WH. 2000. A meta-analysis of hypnotically induced analgesia: how effective is hypnosis Int J Clin Exp Hypn 48: 138-153. crossref(new window)

Murrell J. 2007. Choice of premedicants in cats and dogs. In Practice 29: 100-106. crossref(new window)

Popovic NA, Mullane JF, Yhap EO. 1972. Effects of acetylpromazine maleate on certain cardiorespiratory responses in dogs. Am J Vet Res 33: 1819-1824.

Singh H. 1999. Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia. Eur J Anaesthesiol 16: 31-36. crossref(new window)

Suarez MA, Dzikiti BT, Stegmann FG, Hartman M. 2012. Comparison of alfaxalone and propofol administered as total intravenous anaesthesia for ovariohysterectomy in dogs. Vet Anaesth Analg 39: 236-244. crossref(new window)

Tranquilli WJ, Benson GJ. 1992. Advantages and guidelines for using alpha-2 agonists as anesthetic adjuvants. Vet Clin North Am Small Anim Pract 22: 289-293. crossref(new window)

Turner DM, Ilkiw JE, Rose RJ, Warren JM. 1974. Respiratory and cardiovascular effects of five drugs used as sedatives in the dog. Aust Vet J 50: 260-265. crossref(new window)